SLC5A5 and cervical cancer: NIS-encoding non-replicating ADV, which was studied in thexenografts of various human cancers, including cervical cancer, breast cancer,and prostate cancer (PCa), as well as in immunodeficient mouse models, was thefirst NIS-expressing virus obtained [67].